Analysis of viable CD133+/CD34+AND CD34+stem cell subsets in prediction of haematopoietic engraftment in multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation.

被引：0
|
作者：
Hicks, C. [1 ]
机构：
[1] St George Hosp, Sydney, NSW, Australia
来源：
CYTOTHERAPY | 2006年 / 8卷
关键词：
D O I：
暂无
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] The number of CD34+cells in peripheral blood as a predictor of the CD34+yield in patients going to autologous stem cell transplantation
    Basquiera, A. L.
    Abichain, P.
    Damonte, J. C.
    Ricchi, B.
    Sturich, A. G.
    Palazzo, E. D.
    Garcia, J. J.
    [J]. JOURNAL OF CLINICAL APHERESIS, 2006, 21 (02) : 92 - 95
  • [42] Autologous stem cell transplantation in multiple myeloma: The effect of CD 34+ cell selection.
    Patriarca, F
    Fanin, R
    Damiani, D
    Silvestri, F
    Geromin, A
    Sperotto, A
    Cerno, M
    Grimaz, S
    Stocchi, R
    Baccarani, M
    [J]. BLOOD, 1998, 92 (10) : 370B - 370B
  • [43] Number of viable CD34+ cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation
    Allan, DS
    Keeney, M
    Howson-Jan, K
    Popma, J
    Weir, K
    Bhatia, M
    Sutherland, DR
    Chin-Yee, IH
    [J]. BONE MARROW TRANSPLANTATION, 2002, 29 (12) : 967 - 972
  • [44] Number of viable CD34+ cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation
    DS Allan
    M Keeney
    K Howson-Jan
    J Popma
    K Weir
    M Bhatia
    DR Sutherland
    IH Chin-Yee
    [J]. Bone Marrow Transplantation, 2002, 29 : 967 - 972
  • [45] Endogenous production of cytokines in autologous and allogeneic CD34+ selected peripheral blood stem cell transplantation.
    Vizcarra, E
    Solano, C
    Marugan, I
    Benet, I
    Arbona, C
    Gutiérrez, A
    García-Conde, J
    [J]. BONE MARROW TRANSPLANTATION, 1999, 23 : S82 - S82
  • [46] Endogenous production of cytokines autologous and allogeneic CD34+selected peripheral blood stem cell transplantation.
    Solano, C
    Vizcarra, E
    Gutiérrez, A
    Marugán, I
    Benet, I
    García-Conde, J
    [J]. BLOOD, 1999, 94 (10) : 325B - 325B
  • [47] INTRACORONARY AUTOLOGOUS CD34+STEM CELL THERAPY FOR INTRACTABLE ANGINA
    Wang Shihong
    Wang Shihong
    [J]. HEART, 2012, 98 : E42 - E43
  • [48] Post-thaw viable CD34+cells enumeration and engraftment in autologous stem cell transplantation
    Bartolozzi, B.
    Urbani, S.
    Dal Pozzo, S.
    Guidi, S.
    Donnini, I.
    Sanna, A.
    Gozzini, A.
    Nozzoli, C.
    Saccardi, R.
    Bosi, A.
    [J]. BONE MARROW TRANSPLANTATION, 2012, 47 : S285 - S285
  • [49] Autologous blood stem cell transplantation with CeprateR selected CD34+ cells for multiple myeloma.
    Volin, L
    Juvonen, E
    Elonen, E
    Ruutu, T
    [J]. BONE MARROW TRANSPLANTATION, 1998, 21 : S204 - S204
  • [50] High CD34+ cell dose is a significant factor for hematologic reconstitution of patients with multiple myeloma (MM) or AL-amyloidosis undergoing autologous peripheral blood stem cell transplantation.
    Klaus, J
    Herrmann, D
    Hegenbart, U
    Egerer, G
    Cremer, FW
    Breitkreutz, I
    Benner, A
    Fruehauf, S
    Moehler, T
    Ho, AD
    Goldschmidt, H
    [J]. BLOOD, 2004, 104 (11) : 328A - 328A
12345